Uday R. Popat

Hematology
210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 350 publications

Mismatched Unrelated vs Matched Related Donor Transplant With Posttransplant Cyclophosphamide Among Patients With Blood Cancers.

Mismatched Unrelated vs Matched Related Donor Transplant With Posttransplant Cyclophosphamide Among Patients With Blood Cancers.

Journal: JAMA network open
Published: July 20, 2026

Phenotype-Specific Associations Between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes.

Phenotype-Specific Associations Between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes.

Journal: Transplantation and cellular therapy
Published: June 04, 2026

Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

Journal: Leukemia & lymphoma
Published: June 01, 2026

Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes.

Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes.

Journal: Transplantation and cellular therapy
Published: March 26, 2026

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

Journal: American journal of hematology
Published: March 23, 2026

Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid Leukemia.

Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia
Published: March 12, 2026

Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.

Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.

Journal: Haematologica
Published: March 11, 2026

Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantation.

Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantation.

Journal: Haematologica
Published: March 10, 2026

Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

Journal: Blood advances
Published: March 06, 2026

The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT.

The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT.

Journal: American journal of hematology
Published: February 27, 2026

When remission alone might be good enough.

When remission alone might be good enough.

Journal: Blood advances
Published: February 24, 2026

When remission alone might be good enough.

When remission alone might be good enough.

Journal: Blood advances
Published: February 17, 2026
Showing 1-12 of 350

Last Updated: 09/26/2026